Urogenital ageing

Menopause International

Volumn 4, Issue 4, 1998, Pages 151-156

  Milsom, Ian ^a   Molander, Ulla ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

oestrogen deficiency syndrome; oestrogens; postmenopause; urinary incontinence; urinary tract infections

Indexed keywords

EID: 84990397019     PISSN: 17540453     EISSN: None     Source Type: Journal    
DOI: 10.1177/136218079800400407     Document Type: Review

References (45)

1. Barlow DH, Cardozo LD, Francis RM, Griffin M, Hart DM, Stephens E, Sturdee DW. Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997; 104: 87–91.
2. Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life in elderly women. Age Ageing 1993; 22: 82–89.
3. Iosif CS, Henriksson L, Ulmsten U. The frequency of disorders of the lower urinary tract, urinary incontinence in particular as evaluated by a questionnaire survey in a gynecological health control population. Acta Obstet Gynecol Scand 1981; 60: 71–76.
4. Berg G, Gottqall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60–62 in Linköping, Sweden, in 1986. Maturitas 1988; 10: 193–199.
5. Molander U, Milsom I, Ekelund P, Mellström D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990; 12: 51–60.
6. Barlow DH, Samsioe G, van Geelen JM. A study of European women's experience of urogenital ageing and its management. Maturitas 1997; 27: 239–247.
7. Bartlett JG, Onderdonk AB, Drude E, Goldstein C, Anderka M, Alpert S, McCormack WM, Quantitative bacteriology of the vaginal flora. J Infect Dis 1977; 136. 271–277.
8. Osborne NG, Wright RC, Grubin L. Genital bacteriology: A comparative study of premenopausal women with post-menopausal women. Am J Obstet Gynecol 1979; 135. 195–198.
9. Milsom I, Nilsson L, Brandberg Å Ekelund P Mellström D Eriksson D. Vaginal immunpglobulin A (IgA) levels in postmenopausal women: influence of oestriol therapy. Maturitas 1991; 13: 129–135.
10. Milsom I, Arvidsson L, Ekelund P, Molander U, Eriksson O. Factors influencing vaginal cytology, pH and bacterial flora in elderly women. Acta Obstet Gynecol Scand 1993; 72: 286–291.
11. Baron JA, La Vecchia C Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162: 502–14.
12. Baron JA, Adams P, Ward M. Cigarette smoking and other correlates of cytologic estrogen effect in postmenopausal women. Fertil Steril 1988; 50: 766–71.
13. Hellberg D, Nilsson S, Haley NJ, Hoffman D, Wynder EL. Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and non-smokers. Am J Obstet Gynecol 1988; 158: 910–3.
14. Taylor P. Ganglionic stimulating and blocking agents. In: Goodman Gilman A, Goodman LS, and Gilman A, editors: The Pharmacological basis of Therapeutics, 6th ed. New York: Macmillan Publishing Co. Inc., 1980: 213–4.
15. Nordqvist P, Ekelund P, Edouard L, Svensson M-L Brandberg Å Seeberg S. Catheter-free geriatric care. Routines and consequences for clinical infection, care and economy. J Hosp Inf 1984; 5: 298–304.
16. Brandberg Å Mellström D Persson U Ödegaard K. Urogenital oestrogen deficiency syndrome among women aged 65+: An assessment of the economics of its treatment. IHE Working paper 1991: 1. The Swedish Institute for Health Economics, 1991.
17. Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J 1980; 281: 1243–1245.
18. Hellström L Ekelund P Milsom I Mellström D. The prevalence of urinary incontinence and incontinence aids amongst 85-year old men and women. Age Ageing 1990; 19: 383–9.
19. Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B. The influence of age, parity, oral contraception, hysterectomy and the menopause on the prevalence of urinary incontinence in women. J Urol 1993; 149: 1459–1462.
20. Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women 20–59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997; 76: 74–80.
21. Jolleys J. Reported prevalence of urinary incontinence in women in a general practice. Br Med J 1988; 296: 1300–1302.
22. Elving LB, Foldspang A, Lam GW, Mommsen S. Descriptive epidemiology of urinary incontinence in 3,100 women age 30–59. Scand J Urol Nephrol 1989 Suppl 125: 37–43.
23. Mäkinen JI Grönroos M Kiilholma PJA Tenho TT Pirhonen JP Erkkola RU. The prevalence of urinary incontinence in a randomized population of 5247 adult Finnish women. Int Urogynecol J 1992; 3: 110–113.
24. Brocklehurst JC. Urinary incontinence in the community - analysis of a MORI poll. Br Med J 1993; 306: 832–834.
25. Falconer C, Blomgren B, Johansson O, Ulmsten U, Malmström A Westergren-Thorsson G Ekman-Ordeberg G. Different organization of collgen fibrils in stress-incontinent women of fertile age. Acta Obstet Gynecol Scand 1998; 77: 87–94.
26. Falconer C, Ekman-Ordeberg G Blomgren B Johansson O Ulmsten U Westergren-Thorsson G Malmström A. Parurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand 1998; 77: 95–100.
27. Hu T-W. Impact of urinary incontinence on health-care costs. J Am Geriatr Soc 1990; 38: 292–295.
28. Ekelund P, Grimby A, Milsom I. Urinary incontinence: Social and financial costs high. Br Med J 1993; 306: 1344.
29. Kicovic PM, Cortes-Prieto J Milojevic S Haspels AA Aljinovic A. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: Clinical, endocrinological and safety aspects. Maturitas 1980; 2: 275–282.
30. Mattsson L-A. Cullberg G. A clinical evaluation of treatment with estriol vaginal cream versus suppository in post-menopausal women. Acta Obstet Gynecol Scand 1983; 62: 397–401.
31. Brandberg Å Mellström D Samsioe G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand 1987 (Suppl 140): 33–38.
32. Molander U, Milsom I, Ekelund P, Mellström D Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990; 12: 113–120.
33. Nilsson K, Heimer G. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency - a pharacokinetic and pharmacodynamic study. Maturitas 1992; 15: 121–127.
34. Smith P, Heimer G, Lindskog M, Ulmsten U. Estradiol- releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993; 16: 145–154.
35. Henriksson L, Sternquist M, Boquist L, Ålander U Selenius I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994; 171: 624–632.
36. Stamey TA. The role of introital enterobacteria in recurrent urinary infections. J Urol 1973; 109. 467–472.
37. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–756.
38. Salmon UL, Walter RI, Gast SH. The use of estrogens in the treatment of dysuria and incontinence in postmenopausal women. Am J Obstet Gynecol 1941; 42: 845–847.
39. Judge TDG. The use of quinestradiol in elderly incontinent women: a preliminary report. Gerontol Clin 1969; 11: 159–164.
40. Samsioe G, Jansson I, Mellström D Svanborg A. The occurence, nature and treatment of urinary incontinence in a 70 year old population. Maturitas 1985; 7: 335–342.
41. Walter S, Wolf H, Barlebo H, Jensen HK. Urinary incontinence in postmenopausal women treated with estrogens. A double-blind clinical trial. Urol Int 1978; 33: 135–143.
42. Molander U, Milsom I, Ekelund P, Arvidsson L, Eriksson O. A health care programme for the investigation and treatment of elderly women with urinary incontinence and related urogenital symptoms. Acta Obstet Gynecol Scand 1991; 70: 137–142.
43. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. J Am Geriatr Soc 1990; 38: 326–328.
44. Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: A meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 1994: 83: 12–18.
45. Ahlström K Sandahl B Sjöberg B Ulmsten U Stormby N Lindskog M. Effect of combined treatment with phenyl-propanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.